Beiersdorf’s shares face turbulent times as analysts offer conflicting outlooks following a dramatic 30% plunge from their 2025 peak. The Hamburg-based consumer goods giant triggered a sell-off after slashing its annual revenue forecast, citing disappointing Q2 results—particularly in its core Nivea segment, which grew just 1.5% versus the expected 3%. While one major bank upgraded its rating from "Sell" to "Hold," citing limited downside risk and a decade-low valuation, others maintain buy recommendations despite cutting price targets. The company pins hopes on premium-brand demand recovery and upcoming product launches to revive its fortunes in H2.
Turnaround Hinges on Nivea Revival
Market uncertainty persists as Beiersdorf trades near three-year lows, with its flagship skincare brand underperforming in a slowing market. Operational earnings missed estimates by €15 million, compounding investor skepticism. However, some analysts view the revised guidance as a necessary correction to align expectations, noting potential for rebound in the premium segment. With bearish sentiment prevailing, all eyes are on whether new launches can stem the decline and justify remaining bullish positions.
